title: Reply to V. Pitini et al and L.J. Costa.
authors: Mayo Clinic, Rochester, MN Thompson.Carrie@mayo.edu.
authors: Carrie A
authors: CA
authors: Thompson
authors: Centre Leon Berard, University of Lyon, Lyon, France.
authors: Herve
authors: H
authors: Ghesquieres
authors: Mayo Clinic, Rochester, MN.
authors: Matthew J
authors: MJ
authors: Maurer
authors: Mayo Clinic, Rochester, MN.
authors: James R
authors: JR
authors: Cerhan
authors: University of Iowa Hospitals and Clinics, Iowa City, IA.
authors: Brian K
authors: BK
authors: Link
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents